A Study to Evaluate the Drug Levels and Safety of Pegbelfermin in Healthy Overweight and Obese Chinese and Korean Participants

NCT04649710 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Healthy Participants

Interventions

BIOLOGICAL: BMS-986036
OTHER: Placebo

Sponsor

Bristol-Myers Squibb